Relevant Interviews, Disease and Trial Updates and Stock-Markets News posted by CRISPR Medicine News.

Check also Companies to Follow in 2022 and CMN Markets for the latest stock and market trends.

Always stay updated with the free CMN Newsletter.


Main focus: Next-generation gene-editing systems

Company stage: Pre-clinical

Diseases: Undisclosed

Genome editing tool: CRISPR-Cas9, multiple undisclosed

Funding stage: Private

Location: Everyville, CA, USA


Partners: Moderna, Vor Biopharma

Metagenomi is a start-up gene-editing company that applies its proprietary metagenomics-powered discovery platform to discover and develop next-generation gene-editing systems. The company has yet not disclosed any of its lead programmes, but announced a multi-year, multi-target collaboration with Moderna to develop in vivo gene-editing therapeutics.



Company: Metagenomi
Jobs, banner ads, webinars, sponsored content...
Search CRISPR Medicine